FDA clinical hold on ARD-101, cash-backed valuation, and key catalysts ahead. Click for more on recent developments with AARD ...
With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results